ACADIA PHARMACEUTICALS INC 4
4 · ACADIA PHARMACEUTICALS INC · Filed Apr 20, 2016
Insider Transaction Report
Form 4
Iversen Leslie L
Director
Transactions
- Sale
Common Stock
2016-04-18$33.53/sh−33,697$1,129,999→ 36,127 total - Exercise/Conversion
Common Stock
2016-04-18$1.75/sh+33,697$58,970→ 69,824 total - Exercise/Conversion
Stock option (right to buy)
2016-04-18−33,697→ 0 totalExercise: $1.75Exp: 2021-06-09→ Common Stock (33,697 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $32.875 to $33.85 per share, inclusive.The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
- [F3]25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the grant date of June 10, 2011.